Neurotechnology is advancing at breakneck speed—but can existing patent law keep up? Larissa Bifano, Rebecca Lawrence & Harry Lambert examine the IP challenges facing innovators in the UK & US
- Neurotechnology innovation increasingly depends on AI-driven data processing, raising significant challenges under patent law exclusions for software, mathematical methods, and diagnostic or surgical techniques.
- UK and US patent regimes take different approaches to subject-matter eligibility, inventorship, and technical effect, requiring carefully tailored patent strategies for transatlantic protection.
Neurotechnology continues to advance with increasing sophistication, striving for less invasive interfaces and more precise interaction with the nervous system. However, the efficacy of these devices increasingly depends on how they handle the high-dimensional, noisy data they record.
Innovators are turning to rapidly advancing artificial intelligence (AI) to decode these signals and enable closed-loop control. This reliance on software and algorithms brings the field into direct collision with patent regimes in the UK and US, which maintain strict exclusions for computer programs and mathematical
